Showing results (1361-1370 of 1,526) with videos related to
Sort By:
Pageof 153
Journal of Cardiovascular Electrophysiology|July 5, 2021
Accuracy of automatic abnormal potential annotation for substrate identification in scar-related ventricular tachycardiaYosuke Nakatani, Philippe Maury, Anne Rollin, et al.JACC. Clinical Electrophysiology|April 20, 2019
Use of Novel Electrogram "Lumipoint" Algorithm to Detect Critical Isthmus and Abnormal Potentials for Ablation in Ventricular TachycardiaClaire A Martin, Masateru Takigawa, Ruairidh Martin, et al.Circulation|July 17, 2014
Driver domains in persistent atrial fibrillationMichel Haissaguerre, Meleze Hocini, Arnaud Denis, et al.JACC. Clinical Electrophysiology|July 3, 2025
Linear Ablation at the Mitral Isthmus Following Mitral Valve SurgeryKinan Kneizeh, Thomas Pambrun, Allan Plant, et al.Genome Medicine|February 7, 2025
Imaging flow cytometry-based cellular screening elucidates pathophysiology in individuals with Variants of Uncertain SignificanceIrena Josephina Johanna Muffels, Hans R Waterham, Giuseppina D'Alessandro, et al.Therapeutic Advances in Medical Oncology|September 26, 2022
Plasma-first: accelerating lung cancer diagnosis and molecular profiling through liquid biopsyMiguel Garcia-Pardo, Kasia Czarnecka, Jennifer H Law, et al.Circulation. Arrhythmia and Electrophysiology|May 18, 2018
Comprehensive Multicenter Study of the Common Isthmus in Post-Atrial Fibrillation Ablation Multiple-Loop Atrial TachycardiaMasateru Takigawa, Nicolas Derval, Philippe Maury, et al.Lung Cancer (Amsterdam, Netherlands)|May 25, 2020
EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft modelsSebastiao N Martins-Filho, Jessica Weiss, Nhu-An Pham, et al.Clinical Lung Cancer|May 17, 2025
Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase InhibitorsLouis Pinard, Avinash Rao Ullur, Louis Everest, et al.JTO Clinical and Research Reports|December 17, 2021
Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and EfficacySally C M Lau, Malcolm Ryan, Jessica Weiss, et al.Pageof 153